SCHIZOPHRENIA 1 (Disorder): Clinical Trials

4 trials for SCHIZOPHRENIA 1 (Disorder), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 not yet recruiting. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 2, Completed 1, Not yet recruiting 1
Phase 11Recruiting 1

Follow SCHIZOPHRENIA 1 (Disorder): new trials by email Literature Review of SCHIZOPHRENIA 1 (Disorder) trials Research Report on SCHIZOPHRENIA 1 (Disorder)

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Brain Imaging of DSP-2342
DSP-2342 - SCHIZOPHRENIA 1 (Disorder)
Phase 2Not yet recruitingJohns Hopkins University202027-01-012026-09-30
Confirmatory Trial of Gamma Neurofeedback to Improve Working Memory in Schizophrenia
EEG Neurofeedback - SCHIZOPHRENIA 1 (Disorder), Schizoaffecitve Disorder
Phase 2RecruitingUniversity of California, San Diego1042026-11-052026-11-10
A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
Xanomeline and trospium chloride (KarXT) - SCHIZOPHRENIA 1 (Disorder), Schizoaffecitve Disorder
Phase 1 / Phase 2RecruitingNew York State Psychiatric Institute122026-07-012026-07-14
A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia
HS-10380 Low Dose, HS-10380 Medium dose, HS-10380 High Dose - SCHIZOPHRENIA 1 (Disorder)
Phase 2CompletedJiangsu Hansoh Pharmaceutical Co., Ltd.3632024-05-232026-04-24

Narrower conditions

Schizophrenia (3)

Broader conditions

Mental Disorders (3)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (3)

Interventions

Aripiprazole (1)  ·  trospium chloride (1)  ·  xanomeline (1)

Sponsors

Jiangsu Hansoh Pharmaceutical Co., Ltd. (1)  ·  Johns Hopkins University (1)  ·  New York State Psychiatric Institute (1)  ·  University of California, San Diego (1)

Countries

United States (3)  ·  China (1)

Top investigators

Akira Sawa, MD (1)  ·  Fiza Singh, MD (1)  ·  Joshua T Kantrowitz, MD (1)  ·  Ragy Girgis, MD (1)